NuWays reiterates Buy on MHP Hotel, cuts price target to EUR 3.5
Reuters2026/09/15 07:00- NuWays reiterated a Buy rating on MHP Hotel AG, cutting its 12-month target price to EUR 3.5 from EUR 3.7.
- H1 sales rose 25% year-on-year to EUR 99.3 million; organic growth was 3.8% as new hotels drove most of the increase.
- H1 EBITDA was EUR 0.2 million; NuWays said underlying operating EBITDA improved EUR 1.9 million year-on-year, adjusting for prior one-offs.
- Management cut full-year sales guidance to EUR 220-225 million; EBITDA outlook fell to about EUR 8 million from about EUR 10 million.
- NuWays linked the downgrade to a slower Conrad ramp-up, weaker Middle East demand, higher energy costs; it expects a stronger H2 run-rate.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
XRP Price Saved as It Bounces Over $1.3
GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma
GlaxoSmithKline announced on Tuesday that it has reached an agreement with Chinese biotechnology company ImmuneOnco to acquire the global rights to one of the latter’s trispecific T-cell engagers (TCE) for a total transaction amount of up to $750 million.
Alphabet's Waymo, Local Partners Plan 2027 Tokyo Autonomous Taxi Launch
Germany's DAX 40 fell to 25,200 points, down 0.8% in 24 hours
